蔚來-SW(09866.HK)早段曾升15% 李斌指ET9訂單遠勝預期
蔚來-SW(09866.HK)今日高開14.96%,最高見72.7元,升15.1%,見三個月新高。現報70.1元,升11.01%,成交79.36萬股,涉資5,609.21萬元。
公司在2023蔚來日正式發布ET9,預售價80萬元人民幣,將於2025年首季開付。蔚來行政總裁李斌表示,ET9訂單量遠高於官方預期。
另外,蔚來發表自研智駕晶片「神璣9031」,採用5納米工藝,有超500億個電晶體,目標是用一顆自研晶片實現目前業界四顆旗艦智慧駕駛晶片的性能,以優化效率及成本。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.